ADVANCED ENZYME TECHNOLOGIES
Back to Balance Sheet
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹46 Cr | ₹44 Cr | ₹49 Cr | ₹59 Cr | ₹49 Cr |
What is the latest Total Non-Current Liabilities ratio of ADVANCED ENZYME TECHNOLOGIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹46 Cr |
| Mar2024 | ₹44 Cr |
| Mar2023 | ₹49 Cr |
| Mar2022 | ₹59 Cr |
| Mar2021 | ₹49 Cr |
How is Total Non-Current Liabilities of ADVANCED ENZYME TECHNOLOGIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹46 Cr | 4.54 | |
| Mar2024 | ₹44 Cr | -10.30 | |
| Mar2023 | ₹49 Cr | -17.87 | |
| Mar2022 | ₹59 Cr | 20.87 | |
| Mar2021 | ₹49 Cr | - | |
Compare Total Non-Current Liabilities of peers of ADVANCED ENZYME TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ADVANCED ENZYME TECHNOLOGIES | ₹3,332.9 Cr | 6.8% | 2% | -0.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹397,018.0 Cr | -2.3% | -8.5% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,454.0 Cr | 5.3% | -3.4% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,702.0 Cr | 3.7% | -4.9% | 26% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,830.0 Cr | 1.2% | -4.2% | 5.3% | Stock Analytics | |
| CIPLA | ₹99,325.0 Cr | 2.4% | -7.2% | -18.1% | Stock Analytics | |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ADVANCED ENZYME TECHNOLOGIES | 6.8% |
2% |
-0.9% |
| SENSEX | 5.8% |
-1.7% |
1.2% |
You may also like the below Video Courses